Brief: Carmell Therapeutics Announces Merger With Axolotl Biologix

Longevity Health Holdings

27/07/2023 12:04

July 27 (Reuters) - Carmell Therapeutics Corp  CTCX.O :
    * CARMELL THERAPEUTICS ANNOUNCES MERGER WITH AXOLOTL
BIOLOGIX, A
PROFITABLE REGENERATIVE MEDICINE COMPANY
    * CARMELL THERAPEUTICS: AXOLOTL'S SHAREHOLDERS WILL RECEIVE
$65
MILLION IN INITIAL EQUITY VALUE PLUS UP TO $75 MILLION IN
POTENTIAL MILESTONE EQUITY PAYMENTS
    * CARMELL THERAPEUTICS CORP - UPON CLOSING, AXOLOTL WILL
OPERATE
AS WHOLLY OWNED SUBSIDIARY OF CARMELL

Source text for Eikon:  ID:nBw1S0McBa 
Further company coverage:  CTCX.O 

 ((Reuters.Briefs@thomsonreuters.com;))